Michael Cooper, MD
Cardiovascular Disease · Greensboro, NCNPI 1992929137
Payments from drug & device makers
Across 535 payments — averaging $1145.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$330K
- Novartis$153K
- Abbott$65K
- Biotronik Inc.$31K
- Daiichi Sankyo Inc.$29K
- Boston Scientific$1K
- plus $5K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 40 | $329,746 |
| Novartis | 39 | $153,055 |
| Abbott | 89 | $64,652 |
| Biotronik Inc. | 106 | $30,687 |
| Daiichi Sankyo Inc. | 43 | $28,831 |
| Boston Scientific | 26 | $1,029 |
| Amgen | 54 | $841 |
| Abiomed | 20 | $578 |
| Medtronic(2 entities) | 10 | $494 |
| Shockwave Medical, Inc | 5 | $454 |
| Penumbra, Inc. | 2 | $300 |
| Johnson & Johnson | 18 | $236 |
| Pfizer | 12 | $205 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $201 |
| Cardiovascular Systems Inc. | 8 | $171 |
| Sanofi-aventis U.S. LLC | 7 | $127 |
| Boehringer Ingelheim | 8 | $126 |
| AstraZeneca | 9 | $114 |
| Terumo Medical Corporation | 1 | $111 |
| Chiesi USA, Inc. | 3 | $108 |
| Biosense Webster, Inc. | 2 | $88 |
| Irhythm Technologies, Inc. | 3 | $48 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Merck | 3 | $40 |
| Acist Medical Systems, Inc. | 1 | $36 |
| Bayer | 2 | $31 |
| GSK | 1 | $30 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Scpharmaceuticals Inc. | 1 | $24 |
| Portola Pharmaceuticals, LLC | 1 | $23 |
| Cardiva Medical, Inc. | 1 | $20 |
| Heartflow, Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Teleflex LLC | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
How this compares
$612,574 in reported general payments places this provider in the 90th percentile of 727 cardiovascular disease providers in North Carolina.
See all cardiovascular disease providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Greensboro
- Jagadeesh GanjiGreensboro$1.7M
- Kenneth HiltyGreensboro$1.6M
- Cameron LambertGreensboro$609K
- Bridgette ChristopherGreensboro$261K
- John AlexanderDurham$76.8M
- Christopher GrangerDurham$24.7M
- Jonathan PicciniDurham$14.3M
- Adrian HernandezDurham$13.2M
- Gary FelkerDurham$12.7M
- Robert MentzDurham$6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.